Skip to Main Content

Author Details

Joan Font-Burgada
Fox Chase Cancer Center
2008
23
16
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37310998Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.Proc Natl Acad Sci U S A2023
37310998Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.Proc Natl Acad Sci U S A2023
31606566RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation.Cell Mol Gastroenterol Hepatol2020
32230953Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets.Nutrients2020
32162254Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients.Methods Mol Biol2020
31606566RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation.Cell Mol Gastroenterol Hepatol2020
32230953Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets.Nutrients2020
32162254Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients.Methods Mol Biol2020
30536090Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination.Methods Mol Biol2019
30536090Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination.Methods Mol Biol2019
29487895MHC-I genotype drives early immune selection of oncogenic mutations.Mol Cell Oncol2018
30550793Evolutionary Pressure against MHC Class II Binding Cancer Mutations.Cell2018
30245014Evolutionary Pressure against MHC Class II Binding Cancer Mutations.Cell2018
30287485Integrative genomic analysis of mouse and human hepatocellular carcinoma.Proc Natl Acad Sci U S A2018
29487895MHC-I genotype drives early immune selection of oncogenic mutations.Mol Cell Oncol2018
30245014Evolutionary Pressure against MHC Class II Binding Cancer Mutations.Cell2018
30550793Evolutionary Pressure against MHC Class II Binding Cancer Mutations.Cell2018
30287485Integrative genomic analysis of mouse and human hepatocellular carcinoma.Proc Natl Acad Sci U S A2018
29107334MHC-I Genotype Restricts the Oncogenic Mutational Landscape.Cell2017
29107334MHC-I Genotype Restricts the Oncogenic Mutational Landscape.Cell2017
26771116Obesity and Cancer: The Oil that Feeds the Flame.Cell Metab2016
27211490p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells.Cancer Cell2016
26771116Obesity and Cancer: The Oil that Feeds the Flame.Cell Metab2016
27211490p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells.Cancer Cell2016
25909884Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.Cell Death Differ2015
25924065Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.Nature2015
25916810dDsk2 regulates H2Bub1 and RNA polymerase II pausing at dHP1c complex target genes.Nat Commun2015
25909884Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.Cell Death Differ2015
26276631Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.Cell2015
26276631Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.Cell2015
25924065Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.Nature2015
25916810dDsk2 regulates H2Bub1 and RNA polymerase II pausing at dHP1c complex target genes.Nat Commun2015
24395807Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis.Proc Natl Acad Sci U S A2014
24271395chroGPS, a global chromatin positioning system for the functional analysis and visualization of the epigenome.Nucleic Acids Res2014
24395807Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis.Proc Natl Acad Sci U S A2014
25189770Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.Proc Natl Acad Sci U S A2014
25132496ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development.Cancer Cell2014
25189770Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.Proc Natl Acad Sci U S A2014
25132496ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development.Cancer Cell2014
24271395chroGPS, a global chromatin positioning system for the functional analysis and visualization of the epigenome.Nucleic Acids Res2014
24120137Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.Cell2013
24120137Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.Cell2013
22698394CYLD and HCC: when being too sensitive to your dirty neighbors results in self-destruction.Cancer Cell2012
22698394CYLD and HCC: when being too sensitive to your dirty neighbors results in self-destruction.Cancer Cell2012
18981478Drosophila HP1c isoform interacts with the zinc-finger proteins WOC and Relative-of-WOC to regulate gene expression.Genes Dev2008
18981478Drosophila HP1c isoform interacts with the zinc-finger proteins WOC and Relative-of-WOC to regulate gene expression.Genes Dev2008
  • 1 - 46 of 46

Recommended Authors

Simon Fraser University
Career Start Year 2017
Number of shared co-authors 0
International Research Center, A.C.Camargo Cancer Center
Career Start Year 2016
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
USC Libraries Bioinformatic Services of the University of Southern California
Career Start Year 2012
Number of shared co-authors 2
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
University of California irvine
Career Start Year 2009
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
UPMC Hillman Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Southern California Research Center for ALPD and Cirrhosis
Career Start Year 2006
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Istituto Europeo di Oncologia IRCCS
Career Start Year 2002
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 1
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 0
Oncology R&D
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Career Start Year 1995
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute (NCI)
Career Start Year 1994
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 2

Collaborators

Co-authored papers 12
University of California San Diego
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Universitat Pompeu Fabra
Co-authored papers 5
University of California San Diego
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Columbia University Irving Medical Center
Co-authored papers 3
Co-authored papers 3
Fox Chase Cancer Center
Co-authored papers 2
Co-authored papers 2
University of California
Co-authored papers 2
The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)
Co-authored papers 2
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Pure MHC LLC
Co-authored papers 1
University of California
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Co-authored papers 1
University of California
Co-authored papers 1
Co-authored papers 1
University of California
Co-authored papers 1
University of California, USA Institute for Genomic Medicine
Co-authored papers 1
Co-authored papers 1